期刊文献+

Quantification of flupirtine and its active metabolite D-13223 in human plasma by LC-MS/MS: application to a clinical trial of flupirtine maleate capsules in healthy male Chinese volunteers

LC-MS/MS法同时测定人血浆中氟吡汀及其代谢产物D-13223的浓度:马来酸氟吡汀胶囊在健康男性志愿者中的应用
原文传递
导出
摘要 In the present study, we developed a simple, sensitive, precise, and accurate liquid chromatography-tandem mass spectrometric(LC-MS/MS) method and validated such approach for simultaneous determination of flupirtine and its active metabolite D-13223 in human plasma. The flupirtine, D-13223, and stable isotope internal standard(IS) were extracted from plasma samples by liquid-liquid extraction and chromatographed on a C18 column with a mobile phase consisting of acetonitrile–water–ammonia(55:45:0.1, v/v/v) at a flow rate of 0.25 m L/min. Detection was performed on a triple quadrupole tandem mass spectrometer with an electrospray ionization source(ESI) by multiple reaction monitoring(MRM) in positive ion mode. The linear calibration curves were obtained within the concentration range of 10.00–2000.00 ng/m L for flupirtine and 2.00–400.00 ng/m L for D-13223. The intra-and inter-run RSD, calculated from quality control(QC) samples, was less than 9.26% for flupirtine and D-13223. The accuracy was –5.80%–3.31% for flupirtine and D-13223. The extraction recoveries of flupirtine, D-13223, and their IS were all between 88.3%–97.2%. The method was successfully applied to investigate the pharmacokinetic profiles of flupirtine and its active metabolite D-13223 in human plasma following peroral administration of 100 mg flupirtine maleate capsules in healthy male Chinese volunteers. 建立一种简便、灵敏、准确的液相色谱-串联质谱法以同时测定人血浆中氟吡汀及其活性代谢物D-13223浓度。本文采用三重四级杆液质联用仪,电喷雾电离源(ESI),多反应离子监测(MRM)的正离子模式进行检测,以C18柱为色谱柱,乙腈–水–氨(55:45:0.1,v/v/v)为流动相,液液萃取法提取血浆样品中氟哌汀、D-13223及稳定同位素内标以进行色谱分析。氟吡汀在10.00–2000.00ng/m L浓度范围内线性关系良好,D-13223在2.00–400.00ng/m L浓度范围内线性关系良好。氟吡汀及D-13223质量控制(QC)样品的批内和批间精密度均小于9.26%,准确度范围–5.80%–3.31%。氟吡汀、D-13223及内标的提取回收率均在88.3%–97.2%之间。本法已成功应用于健康男性志愿者口服100mg马来酸氟吡汀胶囊后血浆中氟吡汀及其活性代谢物D-13223的药代动力学研究。
作者 Yanfang Liu Jiashan Zhang Yunbiao Tang Hua Huo 刘艳芳;张嘉珊;唐云彪;霍花(北部战区总医院临床药学技术中心,辽宁沈阳110840;沈阳药科大学生命科学与生物制药学院,辽宁沈阳110840)
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2021年第10期822-830,共9页 中国药学(英文版)
关键词 FLUPIRTINE D-13223 LC-MS/MS Clinical trial 氟吡汀 D-13223 LC-MS/MS 定量测定
  • 相关文献

参考文献3

二级参考文献23

  • 1况荣华,张会杰,熊玉卿.高效液相色谱荧光检测法测定人血浆中替米沙坦浓度及其应用[J].药物分析杂志,2005,25(6):629-632. 被引量:3
  • 2王前.新型非阿片类中枢性镇痛药——氟吡汀[J].中国疼痛医学杂志,2006,12(2):115-117. 被引量:6
  • 3CHEN X Y, ZHONG D F, XU H Y, et al. Simultaneous determi- nation of flupirtine and its major active metabolite in human plasma by chromatography-tandem mass spectrometry[J]. J Chromatography B, 2001, 755(2):195-202.
  • 4FRIEDEL H A, FITTON A. Flupirtine a review of its pharmacological propertics, and therapeatic efficay in pain states [J].Drug, 1993, 45(4) : 548-569.
  • 5Friedel HA, Fittion A. Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states. Drugs, 1993,45 (4) :548.
  • 6Tringali G, Greco MC, Capuano A, et al. Flupirtine inhibits calcito- nin -gene related peptide release from rat brainstem in vitro. Neu- rosci Lett, 2012,506(2) :332.
  • 7Azad SC, Eder M, Simon W, et al. The potassium channel modulator flupirtine shifts the frequency response function of hippocampal syn- apses to favour LTD in mice. Neurosci Lett ,2004,370 (2 -3 ) :186.
  • 8Prabhoo R,Prabhoo T. Flupirtine a novel treatment option for mus- culoskeletal pain disorders. Clin Orthop Trauma ,2011,2 ( 1 ) : 19.
  • 9Devuider J. Flupirtine in pain management : pharmacological proper- ties and clinical use. CNS Drugs,2010,24(10) :867.
  • 10Nickel B. The antinociceptive activity of flupirtine: a structurally new analgesic. Postgrad Med J, 1987,63 ( 3 ) : 19.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部